Showing results (521-530 of 682) with videos related to
Sort By:
Pageof 69
British Journal of Cancer|January 26, 2008
Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysisC L Pearce, A H Wu, S A Gayther, et al.Journal of the National Cancer Institute|February 8, 2014
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association ConsortiumBritton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, et al.Nature Communications|June 22, 2019
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemiaCharles C Bell, Katie A Fennell, Yih-Chih Chan, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2011
MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association ConsortiumJennifer Permuth-Wey, Zhihua Chen, Ya-Yu Tsai, et al.Nature Communications|August 20, 2021
The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncologyGail P Risbridger, Ashlee K Clark, Laura H Porter, et al.Nature Genetics|December 1, 2022
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancerDale W Garsed, Ahwan Pandey, Sian Fereday, et al.Oncotarget|September 9, 2017
Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility geneEd Dicks, Honglin Song, Susan J Ramus, et al.Plos One|February 6, 2013
Inherited variants in regulatory T cell genes and outcome of ovarian cancerEllen L Goode, Melissa DeRycke, Kimberly R Kalli, et al.JCO Oncology Advances|April 1, 2026
Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark AnalysisLuigi A De Vitis, Melissa C Larson, Hunter J Atkinson, et al.Journal of the National Cancer Institute|August 29, 2015
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian CancerSusan J Ramus, Honglin Song, Ed Dicks, et al.Pageof 69